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An 80-year-old Caucasian male was evaluated for delayed
graft function (DGF) following renal transplantation. His past
medical history was significant for end-stage renal disease of
unknown etiology, requiring hemodialysis for 3 years, seizure
disorder, and multiple episodes of nephrolithiasis 430 years
prior. The patient underwent deceased-donor renal transplan-
tation from a 63-year-old male who expired following blunt
head injury. The cold ischemic time was 10.5 h. Following
transplantation the patient had DGF, was discharged on hemo-
dialysis on post-operative day 9, and was re-admitted on day 17
with shortness of breath, electrocardiographic changes, and
elevated troponin levels. Cardiac catheterization revealed two-
vessel disease and angioplasty was performed. By postoperative
day 25 the patient had discontinued dialysis, although his
creatinine level ranged from 3 to 4mg/dl. Owing to the
presence of persistent DGF, allograft biopsy was performed.
Renal allograft biopsy revealed a severe crystalline nephro-
pathy with abundant tubular and interstitial brown,
birefringent crystals (Figure 1a and b). The shape and
birefringent property of the crystals resembled calcium
oxalate, although the brown appearance was distinctive
and suggested the diagnosis of 2,8-dihydroxyadeninuria
(DHA) disease. Oxalate excretion was within the normal
range. The diagnosis of DHA disease was subsequently
supported by the finding of decreased adenine phospho-
ribosyltransferase (APRT) activity on bloodspot. In DHA
disease, deficiency of APRT leads to the conversion of
adenine to DHA, which is largely insoluble in urine, resulting
in nephrolithiasis and, less commonly, a crystalline nephro-
pathy that can recur in the renal allograft. A high index
of suspicion and awareness of this entity is required for
diagnosis.
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Figure 1 | 2,8-Dihydroxyadeninuria disease. (a) Abundant brown crystals are distributed
within the lumen of tubules, cytoplasm of tubular epithelium, and less prominently
within the interstitium (hematoxylin and eosin,  400). (b) The crystals appear strongly
birefringent under polarized light and form distinctive geometric shapes ( 400).
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